CAR-T & Engineered Cell Therapy 1 article

CAR-T & Engineered Cell Therapy follows immune cells deliberately modified to recognize or alter disease, with chimeric antigen receptor T cells as the central model. Target selection, autologous and allogeneic approaches, persistence, toxicity, manufacturing and next-generation cell engineering shape coverage. The section is narrower than Cell & Gene Therapy because the therapeutic agent is an engineered cell; gene delivery matters only insofar as it creates or controls that cellular product.